Product Description
Onco Bcg 40mg Injection is administered by a healthcare professional. It is instilled directly into the bladder through the urethra. For it to be effective, you should complete the course of the vaccine. You should not discontinue even if you get better until the course is completed.
Some common side effects of this medicines include difficulty in urination, urinary tract infection, and fever. These are usually mild and go away with time. However, if they persist or get worse, you should let your doctor know.
Before receiving the vaccine, you should let your doctor if you have ever had an allergic reaction to any vaccine. Also tell your doctor if you have any problems with your heart, kidneys, or liver. Some other medicines may react with this vaccine, so let your doctor know of all the medication you are taking. Pregnant or breastfeeding should consult their doctors first before receiving this vaccine.
Targeted Bladder ImmunotherapyOnco BCG Vaccine is specifically designed for the treatment of superficial (non-invasive) bladder cancer. By introducing the live BCG bacteria directly into the bladder, it stimulates the body's immune system to attack and destroy abnormal cancerous cells, reducing recurrence and progression. This localized approach limits systemic side effects and enhances efficacy in the affected area.
Professional Handling and AdministrationOnco BCG Vaccine must be handled and administered only by trained healthcare professionals in a hospital or clinical setting, using intravesical (bladder) instillation. This ensures precise dosing, strict sterility, and proper patient monitoring for both efficacy and potential side effects. Such professional oversight is crucial for both safety and optimal treatment outcomes.
Strict Storage and Safety ProtocolsThe vaccine is supplied as a lyophilized powder with saline diluent and requires refrigeration between 2C to 8C. It must be protected from light and never injected by any route other than direct bladder instillation. Strict adherence to contraindications-such as avoiding use in immunodeficient or pregnant patients-helps maintain patient safety throughout therapy.
FAQ's of Onco BCG Vaccine:
Q: How is Onco BCG Vaccine administered for bladder cancer treatment?
A: Onco BCG Vaccine is administered intravesically, which means it is delivered directly into the bladder through a catheter. This procedure is performed by a qualified healthcare professional in a hospital or clinical setting.
Q: What is the recommended dosage and treatment schedule for Onco BCG Vaccine?
A: The typical dosage involves dissolving one vial of freeze-dried BCG in 50 ml of saline and instilling it into the bladder once weekly. The exact course and duration are determined by your physician based on your condition.
Q: When should Onco BCG Vaccine not be used?
A: Onco BCG Vaccine is contraindicated for patients with active urinary tract infections, those who are immunodeficient, and pregnant women. It should never be injected by any route other than into the bladder.
Q: Where should Onco BCG Vaccine be stored before use?
A: The vaccine must be stored in a refrigerator at 2C to 8C, protected from light. Keep it out of reach of children and ensure it is only accessed by healthcare professionals.
Q: What are the common side effects of Onco BCG Vaccine?
A: Frequent side effects include dysuria (painful urination), hematuria (blood in urine), increased urinary frequency, and low-grade fever. Always report severe or persistent symptoms to your doctor promptly.
Q: What benefits does Onco BCG Vaccine offer in bladder cancer treatment?
A: Onco BCG Vaccine boosts the immune system's response within the bladder, effectively helping to reduce recurrence and progression of non-invasive bladder cancer, thus improving patient outcomes.
Q: What precautions should be observed during Onco BCG Vaccine treatment?
A: The vaccine is to be used under strict medical supervision, only for intravesical use. Patients must follow all doctor's instructions and notify healthcare providers about any infections or underlying health conditions before starting therapy.